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Two Cases of Co-Infection with Babesiosis and Lyme 
Disease
Anthony DeCicco, MD, B. Niluk Peiris, MD, Cecilia Kelly, MD, Michael Latreille, MD and Donald Jungkind, PhD
Case 1
The patient is a 71-year-old female with past medical history 
significant for hypothyroidism and hyperlipidemia who 
presented to Thomas Jefferson University Hospital (TJUH) with 
complaints of myalgias for 6 weeks duration. The patient stated 
that she had begun an exercise program to lose weight and had 
subsequently noticed body aches and increased fatigue. She had 
presented to an outside hospital with these complaints, was 
told that the etiology was musculoskeletal, and was prescribed 
naproxen for pain relief. The pain did improve slightly with 
the naproxen but she noticed a rash and hives after starting the 
medication and stopped taking it. Her symptoms continued 
for about 6 weeks and she decided to come to our emergency 
department when she was unable to obtain an appointment 
with her primary care physician. She also noted that 2 days prior 
to admission she had an increase in her temperature to 100˚ F. 
She had been feeling fevers since this time coupled with chills 
and sweating. The fevers were not cyclic in nature. 
On presentation the patient noted that her body aches 
were diffuse and constant. The pain itself was a “dull” pain 
and “soreness”. There was no radiation or exacerbating or 
alleviating factors. There were no other associated symptoms 
except the fevers mentioned above. She denied any joint pains 
or swelling, as well as any tenderness to palpation of her muscles 
or joints. She did note that she had mild nasal congestion but 
no rhinorrhea, coughing, or shortness of breath. She also had 
had “tea-colored” urine about 1 day prior to admission but no 
dysuria. She denied any abdominal pains, constipation, nausea, 
vomiting or diarrhea. Her review of systems was positive for 
malaise, increased fatigue and headache, all noted above. She 
denied any respiratory symptoms, abdominal symptoms or 
urinary symptoms. There was no focal muscular pain, joint 
pain, or swelling.
The patient had hypothyroidism controlled with levothyroxine, 
hyperlipidemia controlled with ezetimibe, simvastatin and 
Omega-3-acid ethyl esters, seasonal allergies controlled with 
fexofenadine, and depression controlled with duloxetine. She 
had been stable on these medications and there were no new 
medications started. She was allergic to sulfamethoxazole/ 
trimethoprim and naproxen, with both causing a rash.
She originally immigrated to the United States from Columbia 
in 1972 and had not travelled outside of the United States 
recently. She denied any sick contacts. She worked as a weaver 
in the past but currently worked as a home health aide at a farm 
in rural Pennsylvania. She did report tick and mosquito bites 
in the past but did not recall any new rashes on her body. Her 
family history was significant for a mother with hepatocellular 
carcinoma, deceased, and a father with end-stage renal disease, 
also deceased.
Her physical exam was positive for scant bibasilar crackles 
that cleared with coughing. She did not have any lymphade-
nopathy. Her skin exam revealed no rashes or target lesions. She 
had full strength in all her extremities and did not have a gait 
disturbance. She did not have any meningeal signs or any focal 
neurological deficits. 
Given the nature of her symptoms, the acute nature of her 
fevers, and the time of year, influenza was initially suspected. 
There was also a concern for subacute endocarditis and as 
a result she was admitted to the hospital for further testing. 
Her influenza A and B viral polymerase chain reaction (PCR) 
tests were negative, as was her respiratory viral panel assay. 
Blood cultures and hepatitis B and C serologies were negative. 
Laboratory results (total bilirubin 1.8 mg/dl, direct bilirubin 
0.3 mg/dl and lactate dehydrogenase 325 U/L on admission) 
were concerning for hemolysis, and, given her history of tick 
exposure, thick and thin blood smears were evaluated for 
parasites. Giemsa staining demonstrated inclusion bodies in 
the red blood cells, with a total parasitemia level of 0.07%. She 
was also found to have a positive Lyme antibody, confirmed 
with PCR. This overall clinical presentation was consistent 
with Babesia (B. microti later confirmed with PCR) and Lyme 
co-infection. She was prescribed atovaquone 750mg twice a day 
for 10 days and azithromycin 250mg once a day for 10 days for 
treatment of Babesiosis and doxycycline 100mg twice a day for 
30 days to treat her Lyme disease. Two weeks after discharge she 
had completed her antibiotic course, her strength had returned 
to normal, and all her previous symptoms had resolved. 
Case 2 
A 44-year-old female from suburban Southeastern Pennsylvania 
presented to TJUH with fevers and headache. Her past medical 
history was significant for type 2 diabetes mellitus, obesity, 
pancreatic mucinous cystic neoplasm of the tail of the pancreas 
status post distal pancreatectomy and splenectomy 3 years ago. 
The patient reported that intermittent fevers began 8 days prior 
to presentation, but she was unsure of a pattern or cyclical 
nature. She stated her temperature maximum at home was 103º 
F. Her fevers were associated with intermittent headaches that 
she described as “pounding” in quality and located both at the 
back of her head and behind her eyes. She did not describe it as 
the worst headache of her life. She had occasionally been taking 
acetaminophen and ibuprofen with minimal to no relief of pain. 
She denied abdominal pain, nausea, vomiting, and rash. 
The patient reported travel one month prior to the mountains 
of Northeastern Pennsylvania, where she spent a significant 
amount of time outside in wooded areas. She denied finding 
ticks or bite marks on her body, and had not had any rash since 
that time. Travel history was also notable for a trip to North 
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Carolina 6 months prior to admission and travel to China 10 
years ago.
Physical examination was significant for fever with temperature 
maximum of 103.1º F, tachycardia with heart rate 119 bpm, and 
blood pressure 98/51 mmHg. Skin exam, including inspection of 
scalp, revealed no rash. Examination was otherwise significant 
for obesity. Pupils were equally round, reactive to light and 
anicteric. Neurological examination revealed cranial nerves 2 
through 12 to be intact. Motor function was grossly normal, 
sensation intact throughout.
Laboratory studies revealed leukocytosis with bandemia, 
thrombocytopenia and hemolysis. Electrolyte panel was within 
normal limits. There was a slight transaminitis in a mixed 
hepatocellular/cholestatic pattern. Given her headache and 
fever, lumbar puncture was performed and cerebrospinal fluid 
analysis was unremarkable. A preliminary review of blood smear 
revealed intra-erythrocyte ring forms with an initial parasite 
load of 18%. Polymerase chain reaction for Babesia microti 
deoxyribonucleic acid was positive, confirming suspicion for 
Babesia infection. Serology for HIV, Ehrlichia, Rocky Mountain 
Spotted Fever, Rickettsia yphi, and anaplasmosis was negative. 
Lyme immunoglobulin G and immunoglobulin M antibodies 
were positive. The overall clinical picture was consistent with a 
co-infection of both babesiosis and Lyme disease. Further, given 
her relatively large parasite burden it was determined to treat 
this patient as severe babesiosis. 
Treatment plan included a course of clindamycin and quinine 
for her severe babesiosis, as well as doxycycline to cover Lyme 
disease. The patient’s blood parasite level was monitored, and 
on the second hospital day it increased to 36% from 18%. In 
response to this rapid rise in the parasite burden exchange 
transfusion was implemented; she tolerated this procedure 
without any complications. On the following day her parasite 
load decreased to 0.07% and remained stable around this level. 
Patient was deemed stable and discharged home to finish her 
antibiotic regimen. 
Discussion
Babesiosis is an infectious disease caused by parasitic protozoa 
of the genus Babesia. Human beings are only accidental hosts—
Babesia is normally maintained amongst rodent reservoirs 
and dependent on the Ixodes scapularis tick for transmission. 
As a result, infection typically involves residence in, or travel 
to, locations common to the Ixodes tick: the Northeastern 
and upper Midwestern United States (Figure 1). Most cases 
are reported during the summer and spring months when the 
protozoa is in its nymph or adult stage.2 
Clinical manifestations follow an incubation period of 1-6 
weeks and initially mimic an acute viral infection with gradual 
onset of fever, fatigue and malaise. Unlike Lyme disease, there 
is no rash associated with babesiosis. Laboratory evaluation 
may reveal evidence of hemolysis (low haptoglobin, elevated 
lactate dehydrogenase and indirect bilirubin); a subsequent thin 
peripheral smear will display the characteristic intraerythrocytic 
parasites (Figure 2). Interestingly, the pathognmonic “maltese 
cross” sign (Figure 3) is a relatively rare formation but can be 
appreciated if an erythrocyte is found when the parasite in an 
asexual reproduction. 
In select patients, progression to severe disease can be rapid 
and can include disseminated intravascular coagulation, 
acute respiratory distress syndrome, kidney and heart failure 
and myocardial or splenic infarction. Risk factors for severe 
disease include patient age > 50 years, immunocompromise, 
co-infection with human immunodeficiency virus and, more 
pertinent to our cases, previous splenectomy (Case 2) and 
co-infection with Borrelia (both cases).10
Several sources corroborate the poor outcome associated with 
asplenia, both functional or post-splenectomy.3,9,10,11 In their 
Figure 2. Thin Geimsa smear of peripheral blood showing both 
intra- and extraerythrocytic ring forms
Figure 1. Areas inhabited by Ixodes scapularis. European 
babesiosis, present in all states of Western Europe, involves a 
different species of both Ixodes and Babesia, and classically 
causes a much more severe disease
Blacklegged Tick
(Ixodes scapularis) 
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landmark study, White et al. showed that 10 of 16 (63%) patients 
post-splenectomy experienced severe disease compared to only 
42 of 121 (34%) patients in the control group.10 A European study 
found that babesiosis almost exclusively affects those without 
a functional spleen.7 The exact mechanism by which asplenia 
contributes to severe disease has not yet been elucidated, but 
Vannier et al suggest that the spleen allows for compartmental-
ization of the inflammatory reaction (largely IFN-γ and TNF-α 
based) necessary to activate anti-protozoal macrophages. In the 
absence of this compartmentalization, systemic inflammation 
can develop.9 The spleen is also necessary for removing 
senescent and malformed erythrocytes. In malaria Plasmodium 
falciparum manages to avoid widespread splenic removal of its 
infected erythrocytes through cytoadherence (red blood cell 
sequestration in the capillaries of distant organs).4 This process 
has been demonstrated in Babesia bovis, but is not known to 
occur in Babesia microti, and as a result the spleen may play a 
much larger role in this disease response.9
Another risk factor for severe disease, co-infection with Borrelia 
burgdorferi is also well- documented—unsurprising given that 
up to 1 in 3 New Jersey ticks carry Borellia burgdorferi and 1 
in 11 carry Babesia microti.1 In a recent study, 14 of 70 patients 
(20%) with serologic evidence of babesiosis also had evidence 
of Lyme disease. Co-infected patients experienced more severe 
clinical manifestations and a longer duration of symptoms.5 
While Borrelia remains the overall more common pathogen, 
newer trends show that the incidence of Babesia is on the rise. 
Krause et al reported a four-fold increase in new babesiosis 
cases relative to Lyme disease in Rhode Island.6 Expansion of 
human habitats into areas where the tick and rodent population 
is high will likely lead to continued zoonotic infections, and thus 
co-infection.
It is important to assess for these risk factors because the presence 
of severe disease changes the treatment paradigm. While mild 
illness can be treated with a combination of azithromycin and 
atovaquone, the recommendation for severe disease is paired 
clindamycin (300-600mg IV every 6 hours) and quinine (650 mg 
by mouth every 6 to 8 hours). Doxycycline (100 mg by mouth 
every 12 hours) is added to cover confirmed Borrelia.11 Baseline 
and follow-up electrocardiograms are important in trending 
the corrected QT interval while on quinine. Daily hemoglobin, 
hemolysis labs and blood parasite levels should be monitored 
while the patient remains hospitalized. Significant hemolysis, 
severe disease and/or parasitemia > 10% are all indications 
to begin exchange transfusion therapy.11 As clinical status 
improves and parasite levels remain low, the transition can be 
made to outpatient therapy. There are no specific guidelines for 
the duration of therapy, but in Case 2, the patient was treated 
with 2 weeks of clindamycin/quinine and 3 weeks of doxycycline 
following documented parasite clearance.
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